Several other research firms have also commented on XRAY. Evercore ISI initiated coverage on shares of DENTSPLY SIRONA in a research note on Friday, July 26th. They set an “in-line” rating on the stock. HC Wainwright reaffirmed a “neutral” rating and issued a $57.00 target price (up from $55.00) on shares of DENTSPLY SIRONA in a report on Tuesday, July 9th. Wellington Shields raised shares of DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a report on Friday, August 2nd. BidaskClub raised shares of DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a report on Tuesday, September 24th. Finally, Barrington Research reaffirmed a “buy” rating and issued a $63.00 target price on shares of DENTSPLY SIRONA in a report on Monday, August 5th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $54.57.
NASDAQ:XRAY traded up $1.15 during mid-day trading on Wednesday, hitting $53.63. 1,022,261 shares of the company’s stock were exchanged, compared to its average volume of 1,769,073. DENTSPLY SIRONA has a one year low of $33.93 and a one year high of $59.40. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.08 and a quick ratio of 1.39. The business has a fifty day moving average price of $51.95 and a 200 day moving average price of $53.37. The company has a market cap of $12.02 billion, a PE ratio of 26.68, a P/E/G ratio of 1.92 and a beta of 0.98.
A number of institutional investors have recently modified their holdings of XRAY. Vanguard Group Inc. raised its holdings in DENTSPLY SIRONA by 7.0% in the second quarter. Vanguard Group Inc. now owns 25,969,056 shares of the medical instruments supplier’s stock worth $1,515,556,000 after buying an additional 1,688,546 shares during the last quarter. Nuveen Asset Management LLC purchased a new position in DENTSPLY SIRONA in the second quarter worth about $64,278,000. Eagle Asset Management Inc. raised its holdings in DENTSPLY SIRONA by 2,650.9% in the second quarter. Eagle Asset Management Inc. now owns 952,733 shares of the medical instruments supplier’s stock worth $55,601,000 after buying an additional 918,100 shares during the last quarter. Robeco Institutional Asset Management B.V. raised its holdings in DENTSPLY SIRONA by 1,307.0% in the second quarter. Robeco Institutional Asset Management B.V. now owns 886,027 shares of the medical instruments supplier’s stock worth $51,713,000 after buying an additional 823,052 shares during the last quarter. Finally, AQR Capital Management LLC raised its holdings in DENTSPLY SIRONA by 745.7% in the second quarter. AQR Capital Management LLC now owns 841,581 shares of the medical instruments supplier’s stock worth $48,475,000 after buying an additional 742,064 shares during the last quarter. 94.67% of the stock is owned by institutional investors and hedge funds.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Read More: Do Tariffs Work?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.